Logo Header Menu

Bayer and Exscientia partner to leverage AI-powered drug discovery

Bayer and Exscientia are partnering to deliver AI-powered drug discovery capabilities for cardiovascular disease and oncology Bayer and Exscientia partner to leverage AI-powered drug discovery image

The partnership will see AI-powered drug discovery specialists Exscientia become the first UK company to partner with Bayer for this purpose.

The two parties have agreed on targets for three upcoming projects that Exscientia will undertake.

In return, Exscientia is expected to receive up to €240 million. This will include funds provided upfront, as well as research fees and clinical milestones.

How technology is transforming home healthcare

Technology solutions underpinned by artificial intelligence and automation are on the verge of transforming home healthcare. Read here

“We’re delighted to collaborate with Bayer, a globally recognised pharmaceutical company,” said Professor Andrew Hopkins, CEO of Exscientia. “Since our pioneering Nature papers demonstrating the automated design of small-molecules, we have enhanced our platform and exemplified it commercially, by accelerating the discovery of future drug molecules with partners.”

Exscientia will use its Centaur Chemist platform in an aim to discover potential drugs to cure cardiovascular disease and oncology cases.

This will not be the first UK-based AI-related endeavour that multinational pharmaceuticals firm Bayer has been involved in; back in October, the company launched LifeHub UK, one of many LifeHub health innovation centres around the world.

Dr. Joerg Moeller, head of research and development at Bayer, said of the new partnership with Exscientia: “We are driving forward digital transformation in R&D as we believe that digital technologies such as AI can simplify and speed up the discovery and development of new drugs for patients.

“The collaboration with Exscientia is expected to help us to achieve project milestones earlier and at the same time accelerate timelines by enabling more precise identification of suitable drug targets and lead structures.”

Sign up for Information Age Newsletters

Latest news

divider
Tech and society
Davos 2020: technology’s opportunity in a cohesive and sustainable world

Davos 2020: technology’s opportunity in a cohesive and sustainable world

22 January 2020 / Countries make laws, but Davos makes norms. In this hyperconnected world of today, the cyber [...]

divider
Automotive
AutoInsights: Leveraging a platforms approach

AutoInsights: Leveraging a platforms approach

22 January 2020 / There is a constant stream of new technologies making its way into business. Today it [...]

divider
Releases & Updates
Infosys study reveals digital ceiling for transformation within companies

Infosys study reveals digital ceiling for transformation within companies

22 January 2020 / The Infosys Digital Radar 2020 assessed over 1000 executives around the world on a Digital [...]

divider
Technology
Why should tech companies use tech consultants?

Why should tech companies use tech consultants?

22 January 2020 / Following the news from Source Global Research that the use of tech consultants by tech [...]

divider
Releases & Updates
buguroo launches enhancements to new account fraud prevention

buguroo launches enhancements to new account fraud prevention

22 January 2020 / These enhancements to buguroo‘s anti-fraud solution, bugFraud, are being made in order to help banks [...]

divider
AI & Machine Learning
How Google’s influence on AI is becoming key to business success

How Google’s influence on AI is becoming key to business success

22 January 2020 / Artificial intelligence (AI)’s importance in business is set to increase in 2020 with Google stepping [...]

divider
Tech and society
Dispatches from Davos 2020: Security still top of mind

Dispatches from Davos 2020: Security still top of mind

21 January 2020 / Baby its cold outside, and trust is in the air! After a wondrous opening sing-a-long [...]

divider
AI & Machine Learning
accessiBe aims to get people with disabilities online by 2025

accessiBe aims to get people with disabilities online by 2025

21 January 2020 / It’s tough to imagine that there are still segments of the global population that are [...]

divider
Business & Strategy
Why UK leaders need open technology for the disrupted future

Why UK leaders need open technology for the disrupted future

21 January 2020 / We’re not quite past the post with Brexit, but thankfully, we have moved beyond the [...]

Do NOT follow this link or you will be banned from the site!

Pin It on Pinterest